SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ZymoGenetics ZGEN
An SI Board Since February 2002
Posts SubjectMarks Bans Symbol
210 12 0 ZGEN
Emcee:  Mike McFarland Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
60Here's the label: zymogenetics.com I guess Aschoff can reiterate now, becatuck-1/17/2008
59FDA Approves ZymoGenetics' RECOTHROM(TM) Thrombin, topical (Recombinant) Thurkrw-1/17/2008
58But maybe he's right. It is strange he'd cover them both. Usually a firrkrw-1/16/2008
57So he is clearing the ZGEN position(taking profits) and picking up the OMRI. mjMJ-1/16/2008
56dewophile on IHub notes that Aschoff has ZGEN competitor Omrix (OMRI) as one of tuck-1/16/2008
55Jonathan Aschoff is out with one of his classic 11th hour attacks, starting ZGENtuck-1/16/2008
54Steve This does make one pause and ask what we are doing here in America. LikMJ-12/13/2007
53<i>i keep seeing stories that u.s. biotechs will be bought whole or part bSteve Lokness-12/12/2007
52i keep seeing stories that u.s. biotechs will be bought whole or part by europe bob zagorin-12/12/2007
51Bob; New interest from Europe?; xml.10kwizard.com (Not an original post - FromSteve Lokness-12/12/2007
50so did i... looks like a nice risk / reward scenario here..bob zagorin-11/2/2007
49Bob; Interesting article. Sounds to me as if King is worried. <chuckle> Steve Lokness-11/2/2007
48seattletimes.nwsource.combob zagorin-11/2/2007
47>>ZymoGenetics Reports Positive Phase 1 Results for IL-21 With Nexavar(R) tuck-10/23/2007
46<i>>This article below implies HBV may not be a good target:<</i&DewDiligence_on_SI-10/11/2007
45[Interferon lambda for Hepatitis] "Lambda Interferon Inhibits Hepatitis B tuck-10/6/2007
44[Inverse association between circulating APRIL levels and serological and clinictuck-10/4/2007
43>>ZymoGenetics and Merck Serono Receive FDA Special Protocol Assessment fotuck-10/4/2007
42David MIller of the Biotech Stock Report plugs ZGEN on Minyanville: minyanvilletuck-9/14/2007
41Bruce and a couple others dipped. steveSteve Lokness-8/25/2007
40ZGEN :Thrombin Delayed 3 months; Reiterate Neutral 2007-08-23 03:00 (New York) mopgcw-8/25/2007
39Zymogenetics, Inc.: Three Months Is All - Buy Weakness MORGAN S 2007-08-22 18:56mopgcw-8/25/2007
38mstar: Thesis 07-24-2007 ZymoGenetics has proven expertise in therapeutic proteimopgcw-8/1/2007
37investorshub.comDewDiligence_on_SI-6/19/2007
36ZymoGenetics Establishes Global Collaboration With Bayer HealthCare for Developmnigel bates-6/19/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News